Consistency of Safety and Efficacy of New Oral Anticoagulants across Subgroups of Patients with Atrial Fibrillation

AIMS: The well-known limitations of vitamin K antagonists (VKA) led to development of new oral anticoagulants (NOAC) in non-valvular atrial fibrillation (NVAF). The aim of this meta-analysis was to determine the consistency of treatment effects of NOAC irrespective of age, comorbidities, or prior VK...

Descripción completa

Detalles Bibliográficos
Autores principales: Lega, Jean-Christophe, Bertoletti, Laurent, Gremillet, Cyrielle, Chapelle, Céline, Mismetti, Patrick, Cucherat, Michel, Vital-Durand, Denis, Laporte, Silvy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3951387/
https://www.ncbi.nlm.nih.gov/pubmed/24622012
http://dx.doi.org/10.1371/journal.pone.0091398

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3951387/
https://www.ncbi.nlm.nih.gov/pubmed/24622012
http://dx.doi.org/10.1371/journal.pone.0091398

Ejemplares similares